Effects of long-term oral dipyridamole treatment on coronary microcirculatory function in patients with chronic stable angina: A substudy of the Persantine in Stable Angina (PISA) study

Journal of Cardiovascular Pharmacology

Volumn 48, Issue 3, 2006, Pages 110-116

  Jagathesan, Rohan ^a   Rosen, Stuart D ^a   Foale, Rodney A ^a   Camici, Paolo G ^a,c   Picano, Eugenio ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Adenosine; Angiogenesis; Coronary flow reserve; Dipyridamole

Indexed keywords

ADENOSINE; ANTIANGINA PECTORIS AGENT; ATROPINE; DEUTERIUM; DIPYRIDAMOLE; DOBUTAMINE; OXYGEN 15; PLACEBO;

ADD ON THERAPY; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EXERCISE TEST; FEMALE; HEART MUSCLE; HEART MUSCLE BLOOD FLOW; HUMAN; LONG TERM CARE; MALE; MICROCIRCULATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STABLE ANGINA PECTORIS;

ADMINISTRATION, ORAL; ADULT; AGED; ANGINA PECTORIS; CORONARY CIRCULATION; DIPYRIDAMOLE; EXERCISE; FEMALE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; TIME FACTORS;

EID: 33749861275     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000245404.20922.9f     Document Type: Article

References (40)

1. Sacks HS, Ancona-Berk VA, Berrier J, et al. Dipyridamole in the treatment of angina pectoris: a meta-analysis. Clin Pharmacol Ther. 1988;43:610-615.
2. Meininger CJ, Granger HJ. Mechanisms leading to adenosine-stimulated proliferation of microvascular endothelial cells. Am J Physiol. 1990;258:H198-H206.
3. Hashimoto E, Kage K, Ogita T, et al. Adenosine as an endogenous mediator of hypoxia for induction of vascular endothelial growth factor mRNA in U-937 cells. Biochem Biophys Res Commun. 1994;204:318-324.
4. Grant MB, Tarnuzzer RW, Caballero S, et al. Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells. Circ Res. 1999;85:699-706.
5. Symons JD, Firoozmand E, Longhurst JC. Repeated dipyridamole administration enhances collateral-dependent flow and regional function during exercise: a role for adenosine. Circ Res. 1993;73:503-513.
6. Torry RJ, O'Brien DM, Connell PM, et al. Dipyridamole-induced capillary growth in normal and hypertrophic hearts. Am J Physiol. 1992;262:H980-H986.
7. Meininger CJ, Schelling ME, Granger HJ. Adenosine and hypoxia stimulate proliferation and migration of endothelial cells. Am J Physiol. 1988;255:H554-H562.
8. Schaper W, Sharma HS, Quinkler W, et al. Molecular biologic concepts of coronary anastomoses. J Am Coll Cardiol. 1990;15:513-518.
9. Smits P, Williams SB, Lipson DE, et al. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans. Circulation. 1995;92:2135-2141.
10. Wang T, Mentzer RM Jr, Van Wylen DG. Interstitial adenosine with dipyridamole: effect of adenosine receptor blockade and adenosine deaminase. Am J Physiol. 1992;263:H552-H558.
11. German DC, Kredich NM, Bjornsson TD. Oral dipyridamole increases plasma adenosine levels in human beings. Clin Pharmacol Ther. 1989;45:80-84.
12. Schaper W. Dipyridamole: an underestimated vascular protective drug. Cardiovasc Drugs Ther. 2005;19:357-363.
13. Picano E. Dipyridamole in chronic stable angina pectoris; a randomized, double blind, placebo-controlled, parallel group study. Eur Heart J. 2001;22:1785-1793.
14. Simons M, Bonow RO, Chronos NA, et al. Clinical trials in coronary angiogenesis: issues, problems, consensus: an expert panel summary. Circulation. 2000;102:E73-E86.
15. De Silva R, Camici PG. Role of positron emission tomography in the investigation of human coronary circulatory function. Cardiovasc Res. 1994;28:1595-1612.
16. Kaufmann PA, Gnecchi-Ruscone T, Yap JT, et al. Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurements with 15O-labeled water and PET. J Nucl Med. 1999;40:1848-1856.
17. Hermansen F, Ashburner J, Spinks TJ, et al. Generation of myocardial factor images directly from the dynamic oxygen- 15-water scan without use of an oxygen-15-carbon monoxide blood-pool scan. J Nucl Med. 1998;39:1696-1702.
18. Hermansen F, Bloomfield PM, Ashburner J, et al. Linear dimension reduction of sequences of medical images, II: direct sum decomposition. Phys Med Biol. 1995;40:1921-1941.
19. Hermansen F, Lammertsma AA. Linear dimension reduction of sequences of medical images, III: factor analysis in signal space. Phys Med Biol. 1996;41:1469-1481.
20. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358-367.
21. Hermansen F, Rosen SD, Fath-Ordoubadi F, et al. Measurement of myocardial blood flow with oxygen-15 labelled water: comparison of different administration protocols. Eur J Nucl Med. 1998;25:751-759.
22. Camici PG, Marraccini P, Lorenzoni R, et al. Coronary hemodynamics and myocardial metabolism in patients with syndrome X: response to pacing stress. J Am Coll Cardiol. 1991;17:1461-1470.
23. Uren NG, Melin JA, De Bruyne B, et al. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med. 1994;330:1782-1788.
24. Vanoverschelde JL, Wijns W, Depre C, et al. Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of noninfarcted collateral-dependent myocardium. Circulation. 1993;87:1513-1523.
25. Fischer S, Sharma HS, Karliczek GF, et al. Expression of vascular permeability factor/vascular endothelial growth factor in pig cerebral microvascular endothelial cells and its upregulation by adenosine. Brain Res Mol Brain Res. 1995;28:141-148.
26. Pasini FL, Guideri F, Ferber D, et al. Pharmacological preconditioning of ischemic heart disease by low-dose dipyridamole. Int J Cardiol. 1996;56:17-27.
27. Picano E, Michelassi C. Chronic oral dipyridamole as a "novel" antianginal drug: the collateral hypothesis. Cardiovasc Res. 1997;33:666-670.
28. Picano E. Stress echocardiography: from pathophysiological toy to diagnostic tool. Circulation. 1992;85:1604-1612.
29. Strauer BE, Heidland UE, Heintzen MP, et al. Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty by intracoronary application of dipyridamole: impact on hemodynamic function and left ventricular performance. J Am Coll Cardiol. 1996;28:1119-1126.
30. Guideri F, Capecchi PL, Acampa M, et al. Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia: a stress echocardiographic study. Int J Cardiol. 2002;83:209-215.
31. Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502.
32. Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354:1706-1717.
33. Giordano FJ. Angiogenesis: mechanisms, modulation, and targeted imaging. J Nucl Cardiol. 1999;6:664-671.
34. Villanueva FS, Abraham JA, Schreiner GF, et al. Myocardial contrast echocardiography can be used to assess the microvascular response to vascular endothelial growth factor-121. Circulation. 2002;105:759-65.
35. Gliozheni E, Picano E, Bernardino L, et al. Angiographically assessed coronary collateral circulation increases vulnerability to myocardial ischemia during vasodilator stress testing. Am J Cardiol. 1996;78:1419-1424.
36. Beleslin BD, Ostojic M, Djordjevic-Dikic A, et al. Integrated evaluation of relation between coronary lesion features and stress echocardiography results: the importance of coronary lesion morphology. J Am Coll Cardiol. 1999;33:717-726.
37. Skopicki HA, Abraham SA, Picard MH, et al. Effects of dobutamine at maximally tolerated dose on myocardial blood flow in humans with ischemic heart disease. Circulation. 1997;96:3346-3352.
38. Cronstein BN. Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol. 1994;76:5-13.
39. Kusmic C, Picano E, Busceti CL, et al. The antioxidant drug dipyridamole spares the vitamin E and thiols in red blood cells after oxidative stress. Cardiovasc Res. 2000;47:510-514.
40. Singh JP, Rothfuss KJ, Wiernicki TR, et al. Dipyridamole directly inhibits vascular smooth muscle cell proliferation in vitro and in vivo: implications in the treatment of restenosis after angioplasty. J Am Coll Cardiol. 1994;23:665-71.